PDT Partners, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,180,000
+5.4%
65,991
+43.8%
0.08%
+14.9%
Q2 2021$1,120,000
+162.3%
45,892
+184.7%
0.07%
+138.7%
Q1 2021$427,000
+145.4%
16,120
-29.6%
0.03%
+158.3%
Q4 2020$174,000
-29.8%
22,912
-53.7%
0.01%
-25.0%
Q3 2020$248,000
-30.5%
49,500
-17.1%
0.02%
-33.3%
Q2 2020$357,00059,7420.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Abbot Financial Management, Inc. 1,411,775$25,243,00011.48%
Flagship Pioneering Inc. 38,506,526$688,497,0007.21%
Artal Group S.A. 4,155,625$74,303,0001.66%
HARBOURVEST PARTNERS LLC 986,878$17,645,0001.66%
Nan Fung Group Holdings Ltd 56,768$1,015,0000.32%
Lombard Odier Asset Management (Switzerland) SA 245,013$4,381,0000.27%
Bellwether Advisors, LLC 29,383$525,0000.18%
PDT Partners, LLC 65,991$1,180,0000.08%
Virtus ETF Advisers LLC 7,478$134,0000.06%
HITE Hedge Asset Management LLC 24,911$445,0000.06%
View complete list of RUBIUS THERAPEUTICS INC shareholders